Jon Patton | Director of Investor Relations and Communication |
Matt Coffey | President and Chief Executive Officer |
Andrew de Guttadauro | Global Head of Business Development |
Kirk Look | Chief Financial Officer |
John Newman | Canaccord |
Wangzhi Li | Ladenburg |
Good afternoon and welcome to Oncolytics Biotech's Third Quarter 2020 Conference Call. All participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company's request. I'd like to turn the call over to Jon Patton, Director of Investor Relations and Communication.